About Butler

Update My Profile
If you are a Butler faculty or staff member click the above link to login and update your profile.

Search more Faculty and Staff

Knoderer, Chad

Associate Professor of Pharmacy Practice
College of Pharmacy/Health Science


Pharmacy Building - 101C

Academic/Professional/Personal Focus

Areas of Expertise

  • Pediatric Pharmacotherapy (Infectious Diseases, Nephrology, Cardiology)

Contributions: (published works or studies, conference presentations)

Selected Contributions:

  • Knoderer CA, Nichols KR, Lyon KC, Veverka MM, Wilson AC.  Are elevated vancomycin serum trough concentrations achieved within the first 7 days of therapy associated with acute kidney injury in children?  J Ped Infect Dis 2013; doi:10.1093/jpids/pit076.

  • Misurac JM, Knoderer CA, Leiser JD, Nailescu C, Wilson AC, Andreoli SP.  Nonsteroidal anti-inflammatory drugs are an important cause of acute kidney injury in children.  J Pediatr 2013 Jan 26. doi:pii: S0022-3476(12)01403-5. 10.1016/j.jpeds.2012.11.069. [Epub ahead of print]
  • Cox EG, Knoderer CA, Jennings A, Brown JW, Rodefeld MD, Walker SG, Turrentine MW. A randomized, controlled trial of catheter-related infectious event rates using antibiotic-impregnated catheters vs. conventional catheters in pediatric cardiovascular surgery patients. J Ped Infect Dis 2012; doi: 10.1093/jpids/pis066 
  • Nichols KR, Knoderer CA, Cox EG, Kays MB.  System wide implementation of the use of extended infusion piperacillin-tazobactam dosing strategy: feasibility of utilization from a children's hospital perspective. Clin Ther 2012;34:1459-65. 
  • Morris JL, Knoderer CA.  Assessment of web-based training (WBT) modules on learning facilitation for advanced pharmacy practice experiences (APPE) in pediatrics.  J Pediatr Pharmacol Ther 2011;16(3):210-15.
  • Knoderer CA, Knoderer HM.  Hyperphosphatemia in pediatric oncology patients receiving liposomal amphotericin B.  J Pediatr Pharmacol Ther 2011;16(2):87-91.
  • Miller LE, Knoderer CA, Cox EG, Kleiman MB.  Assessment of the validity of reported antibiotic allergic reactions in pediatric patients.  Pharmacotherapy 2011;31:736-41.
  • Knoderer CA, Cox EG, Berg MD, Webster AH, Turrentine MW.  Limiting post-operative cefuroxime prophylaxis in children after cardiovascular surgery.  Am J Healt Syst Pharm 2011;68(10):909-14.
  • Knoderer CA, Saft SA, Walker SG, Rodefeld MD, Turrentine MW, Brown JW, Healy DP, Sowinski KM. Cefuroxime pharmacokinetics in pediatric cardiovascular surgery patients undergoing cardiopulmonary bypass.  J Cardiothorac Vasc Anesth 2011;25(3):425-30. Epub 2010 Sep 23.
  • Huddleston AJ, Knoderer CA, Morris JL, Ebenroth ES. Sildenafil for the treatment of pulmonary hypertension in pediatric patients. Pediatr Cardiol 2009;30:871-82.
  • Oen EM, Doan KA, Knoderer CA, Knoderer HM.  Recombinant factor VIIa for bleeding in non-hemophiliac pediatric patients.  J Pediatr Pharmacol Ther 2009;14:37-46.
  • Knoderer CA, Anderson EM, Cox EG.  Survey of congenital heart surgeons' preferences for antimicrobial prophylaxis for pediatric cardiac surgery patients.  Am J Healt Syst Pharm 2008;65:2008-10.
  • Lee JE, Hillier SC, Knoderer CA.  Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.  J Intensive Care Med 2008;23:329-34.
  • Knoderer CA, Everett JA, Buss WF.  Clinical issues surrounding once-daily aminoglycoside dosing in children.  Pharmacotherapy 2003;23(1):44-56.


Butler Assignment (classes or work duties)

  • Director for Clinical and Health Outcomes Research, Pharmacy Practice
  • RX 527 Biostatistics and Research Design
  • RX 641 Pediatric Pharmacotherapy




  • Doctor of Pharmacy Degree from Butler University College of Pharmacy and Health Sciences in 1999.
  • Completed an American Society of Health-System Pharmacists-accredited Post-graduate year-1 (PGY-1)Pharmacy Practice Residency at Clarian Health in 2000.
  • Completed an American Society of Health-System Pharmacists-accredited Post-graduate year-1 (PGY-2)Pediatric Pharmacy Residency at Riley Hospital for Children - Clarian Health in 2001.

Professional Experience
Upon completion of his post-graduate residency training at the Riley Hospital for Children in Indianapolis, Indiana in 2001, Dr. Knoderer accepted a Pediatric Clinical Pharmacist Position at St. Vincent Hospital in Indianapolis. Dr. Knoderer returned to Riley Hospital for Children in 2002 as a Clinical Pharmacist for Pediatric Cardiology and Cardiovascular Surgery, Infectious Diseases, and Nephrology. In 2008, Dr. Knoderer joined the faculty at Butler University College of Pharmacy and Health Sciences. He maintains a practice site at Riley Hospital for Children in Pediatric Infectious Diseases and Nephrology. He also serves as the Program Director for the post-graduate year-2 (PGY2) Pediatric Pharmacy Residency at Riley Hospital for Children - Clarian Health.